跳至主要内容
临床试验/NCT04560114
NCT04560114已完成2 期

Effect of Inhaled Aromatherapy on Chemo-Induced Nausea Vomiting (NCVI): CINVAROM (Chemotherapy Induced Nausea Vomiting and AROMatherapy)

Centre Francois Baclesse2 个研究点 分布在 1 个国家目标入组 96 人开始时间: 2020年12月14日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
96
试验地点
2
主要终点
Number of episodes of nausea and vomiting

研究概览

简要总结

The investigator wish to provide a blend of two essential oils with comparable antiemetic properties; Peppermint essential oil (Mentha x Piperita) and lemon tree essential oil (Citrus Limon). Dry inhalation of these essential oils is safe, but effectiveness has not been determined. Studies on the subject present a questionable methodology. This is why we are proposing this study to measure the effectiveness of this mixture of essential oils on chemo-induced nausea and vomiting.

This study is a first step before a possible study to compare the effects of essential oils with those of a placebo.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients will be eligible if:
  • Aged over 18,
  • Presenting a solid tumor in the 1st line of chemotherapy administered by intravenous route;
  • Treated with adjuvant or neoadjuvant chemotherapy;
  • Affiliated with a social security scheme;
  • Able to understand the meaning of the questions asked;
  • Having given their written consent to participate in the study;
  • Whether or not treated with surgery and radiotherapy before entering the study

排除标准

  • Patients who:
  • Do not give their consent to participate;
  • Do not master the French language;
  • Are deprived of their liberty, under guardianship or curatorship;
  • Suffer from cognitive deficits or associated psychiatric disorders that could compromise their ability to participate in the study (eg: schizophrenia);
  • Are undergoing radiotherapy;
  • Must receive a combination of radio-chemotherapy;
  • Whose chemotherapy protocol is composed of several chemotherapy administrations per week during a course of treatment;
  • have been previously treated with chemotherapy;
  • Have an occlusive syndrome;
  • Have primary cancer of the central nervous system or brain metastases;
  • Have cancer of the Upper Aero Digestive Tract;
  • Simultaneously participate in a therapeutic clinical trial;
  • Have an intolerance to a component of essential oils;
  • Pregnant or breastfeeding.

研究组 & 干预措施

Essential oils

Experimental

Inhalation will be carried out via an inhaler stick containing essential oils (Mentha x Piperita; Citrus Limon; Zingiber Officinale)

干预措施: Essential oils (Drug)

结局指标

主要结局

Number of episodes of nausea and vomiting

时间窗: 4 days after the first cycle of chemotherapy

Number of Episodes of Nausea and Vomiting

时间窗: 4 days after the start of the first cycle of chemotherapy (5 days after inclusion in the study)

The proportion of patients experiencing acute and/or delayed nausea and vomiting, as diagnosed using the MASCC MAT antiemetic tool within 4 days of the first cycle of chemotherapy. Each cycle of chemotherapy lasted one month. We evaluated this criterion 4 days after the start of the first cycle of chemotherapy (5 days after inclusion in the study).

次要结局

  • Number of episodes of nausea and vomiting(4 days after the third cycle)
  • Anxiety with self-questionnaire HADS(21 days after the third cycle)
  • Number of Episodes of Nausea and Vomiting(4 days after the start of the third cycle of chemotherapy (2 months after inclusion).)
  • Anxiety With Self-questionnaire HADS(the last day of the third cycle of chemothrapy (3 months after inclusion))

研究者

发起方
Centre Francois Baclesse
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验